UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer Journal article
Nature Communications, 2022,Volume: 13,Issue: 1
Authors:  Wong, Chi Chun;  Wu, Jian Lin;  Ji, Fenfen;  Kang, Wei;  Bian, Xiqing;  Chen, Huarong;  Chan, Lam Shing;  Luk, Simson Tsz Yat;  Tong, Samuel;  Xu, Jiaying;  Zhou, Qiming;  Liu, Dabin;  Su, Hao;  Gou, Hongyan;  Cheung, Alvin Ho Kwan;  To, Ka Fai;  Cai, Zongwei;  Shay, Jerry W.;  Yu, Jun
Favorite |  | TC[WOS]:2 TC[Scopus]:2 | Submit date:2023/01/30
PCSK9 Inhibition: From Current Advances to Evolving Future Journal article
Cells, 2022,Volume: 11,Issue: 19
Authors:  Liu, Chunping;  Chen, Jing;  Chen, Huiqi;  Zhang, Tong;  He, Dongyue;  Luo, Qiyuan;  Chi, Jiaxin;  Hong, Zebin;  Liao, Yizhong;  Zhang, Shihui;  Wu, Qizhe;  Cen, Huan;  Chen, Guangzhong;  Li, Jinxin;  Wang, Lei
Favorite |  | TC[WOS]:1 TC[Scopus]:1 | Submit date:2022/11/07
Cardiovascular Disease  Clinical Applications  Pcsk9 Inhibitors  Research Status  Security